Bruker Corp. Aktie
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -1,84 % | 4,50 % | -9,15 % | -25,50 % | -16,79 % | - | - |
| Healthequity Inc. | -1,54 % | -3,03 % | -11,11 % | -37,25 % | -17,95 % | 4,92 % | -7,25 % |
| Omnicell Inc. | -2,81 % | 1,76 % | -15,20 % | -4,95 % | -10,82 % | -35,33 % | -67,05 % |
| Myriad Genetics | -4,90 % | 6,59 % | -17,45 % | -63,05 % | -26,79 % | -78,17 % | -84,77 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




